https://www.selleckchem.com/pr....oducts/gsk923295.htm
Several non-invasive scoring systems have been developed and validated worldwide to predict the risk of liver fibrosis in nonalcoholic fatty liver disease (NAFLD). However, information about the performance of these systems in Latin American populations is scarce. Our aim was to evaluate the performance of the Hepamet Fibrosis Score, Fibrosis-4 (FIB-4) and the NAFLD Fibrosis Score (NFS) in a mixed Latin American group of NAFLD patients. Clinical, laboratory and liver biopsy data collected from 379 biopsy-proven NAFLD patients from Lat
Like
Comment
Share
